Introduction to Sanuwave's New Partnership
Sanuwave Health, Inc. (NASDAQ: SNWV) is excited to share that its innovative product line, UltraMIST, is now part of Healogics' Group Purchasing Organization (GPO). This collaboration aims to enhance wound care options for healthcare providers, including Wound Care Centers®, home health agencies, and skilled nursing facilities.
About UltraMIST and Its Benefits
UltraMIST is a groundbreaking, non-invasive technology designed to facilitate effective wound healing. By integrating this product into the Healogics iSupply system, Sanuwave broadens access to advanced treatment solutions for patients with chronic wounds. This partnership signifies a commitment to enhancing patient outcomes through state-of-the-art wound care technology.
Collaboration with Healogics
In light of this partnership, Sanuwave's CEO Morgan Frank expressed enthusiasm about working with Healogics, a recognized leader in wound care. He remarked that this collaboration presents a vital opportunity to support innovative healing solutions within the Healogics network.
Plans for Implementation
Sanuwave intends to roll out the UltraMIST system across various locations affiliated with Healogics by the end of the year. This rollout aims to improve accessibility to high-quality wound care technologies for millions of patients in need.
Impact on Wound Care Practices
The inclusion of UltraMIST in Healogics' offerings provides significant advantages. It reflects a strategic move towards aligning innovative medical technologies with the growing needs of wound care providers. Healogics has been a pioneer in this field for nearly three decades, focusing on evidence-based practices that enhance patient recovery.
Insights from Healogics Leadership
Richard Galentino, President of Healogics Wound Care Supply, mentioned that the organization continuously seeks partnerships with innovative firms like Sanuwave. Their goal is to provide members with access to top-notch medical solutions that are cost-effective while delivering exemplary patient care.
About Sanuwave's Technology
Sanuwave is committed to advancing the field of medical technology, particularly through its research and development efforts. The company specializes in non-invasive systems that stimulate biological responses in patients, aiding in the repair and regeneration of skin and related tissues.
Commitment to Excellence
By partnering with Healogics, Sanuwave strengthens its position as a prominent player in regenerative medicine. The company's focus remains on delivering products that not only restore normal healing processes but also enhance overall patient outcomes.
Further Insights into Healogics
Healogics stands at the forefront of wound care, armed with the largest database of chronic wound outcomes in the country. This data-driven approach, combined with the Wound Science Initiative, showcases their commitment to excellence in patient care.
Future Prospects
The collaboration is anticipated to pave the way for future innovations in wound care. Both companies are dedicated to pushing the boundaries of what is possible in medical science while ensuring that patients receive the highest level of care.
Conclusion
The partnership between Sanuwave and Healogics represents a significant milestone in enhancing wound treatment solutions. As UltraMIST becomes available to GPO members, patients can look forward to improved healing processes that incorporate the latest advancements in medical technology.
Frequently Asked Questions
What is UltraMIST?
UltraMIST is a non-invasive wound care technology that promotes healing through advanced medical techniques.
What is the role of Healogics in this partnership?
Healogics integrates UltraMIST into its GPO, expanding access to innovative wound care for healthcare facilities nationwide.
When will UltraMIST be available to Healogics members?
The UltraMIST rollout is planned by the end of the year at select locations within the Healogics network.
Who leads Sanuwave Health?
Sanuwave Health is led by CEO Morgan Frank, who is passionate about advancing wound care technologies.
Why is this partnership important for wound care?
This collaboration aims to enhance patient care, offering cutting-edge solutions that can significantly improve healing outcomes.
